Nationals take SS Eli Willits, son of ex-MLBer Reggie, with No. 1 pick in draft The 17-year-old Willits is the youngest player ever taken No. 1 overall.

Kade Anderson has emerged as the favorite to be selected No. 1 overall by the Washington Nationals in the 2025 MLB draft, but there is a possibility that high-school shortstop Eli Willits could ...

Arch may come from the most famous quarterback family in football, but his game doesn't bear that strong a resemblance Peyton or Eli.

Shane Gillis will host the 2025 ESPYs, ESPN’s annual awards show. The ESPYs — short for Excellence in Sports Performance Yearly Awards — will take place at Los Angeles’ Dolby Theatre on ...

Shane Gills will host ESPN's annual awards show, the ESPYS, the network announced Tuesday. The ceremony, which honors the top athletes and sports moments of the past year, will be held in Los ...

Comedian and actor Shane Gillis is set to host the ESPY Awards on July 16. The 33rd annual ESPYs will be held at Dolby Theatre in Los Angeles.

Walmart Is Selling a Backpack Cooler for Almost 90% Off, and Shoppers Say It 'Keeps Everything Very Cold All Day' “Comfortable to wear and easier than carrying a cooler.” ...

Some doctors are concerned that patients taking weight loss drugs like Wegovy may be losing too much lean mass. A combination therapy might change that.

Gillis built a bro-comedy fan base and endured a quasi cancellation. With his Netflix sitcom “Tires,” he’s trying to map the leap from edgelord to the mainstream.

An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new challenger to blockbusters from Novo Nordisk A/S and Eli Lilly & Co.

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and Ozempic for weight loss and lowering blood sugar.

The acquisition aligns with Eli Lilly’s broader diversification strategy beyond its core diabetes and obesity treatment portfolio.